PRELUDE-ATK Study

About Cagent Vascular

Cagent Vascular is a commercial-stage medical device innovator focused on transforming vessel preparation in peripheral vascular interventions. Its core technology, Serration Remodeling Therapy (SRT), uses a serrated balloon catheter to apply controlled, low-pressure point force to arterial lesions, aiming to reduce vessel recoil, minimize dissections, and decrease the need for bailout stenting. With its Serranator product line already on the market and supported by prospective clinical data, the company is targeting the large and growing market for peripheral angioplasty by positioning its technology as a new standard of care. Cagent is expanding its product portfolio and actively conducting comparative clinical studies to further validate its approach.

Therapeutic Areas